Susquehanna International Group’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $92.4M | Sell |
556,200
-27,200
| -5% | -$4.46M | 0.01% | 878 |
|
|
2025
Q4 | $93M | Buy |
583,400
+202,800
| +53% | +$27.8M | 0.01% | 932 |
|
|
2025
Q3 | $35.6M | Sell |
380,600
-40,300
| -10% | -$2.85M | ﹤0.01% | 1632 |
|
|
2025
Q2 | $24M | Buy |
420,900
+102,800
| +32% | +$5.45M | ﹤0.01% | 1821 |
|
|
2025
Q1 | $19.4M | Sell |
318,100
-95,300
| -23% | -$8.12M | ﹤0.01% | 1767 |
|
|
2024
Q4 | $37.2M | Buy |
413,400
+162,100
| +65% | +$19.1M | 0.01% | 1341 |
|
|
2024
Q3 | $32.4M | Buy |
251,300
+43,100
| +21% | +$5.62M | 0.01% | 1411 |
|
|
2024
Q2 | $23.6M | Sell |
208,200
-76,000
| -27% | -$8.14M | ﹤0.01% | 1565 |
|
|
2024
Q1 | $37.7M | Sell |
284,200
-53,300
| -16% | -$6.96M | 0.01% | 1227 |
|
|
2023
Q4 | $41.2M | Buy |
337,500
+254,505
| +307% | +$19.5M | 0.01% | 1174 |
|
|
2023
Q3 | $6.32M | Sell |
82,995
-41,180
| -33% | -$4.23M | ﹤0.01% | 3170 |
|
|
2023
Q2 | $14.7M | Buy |
124,175
+50,445
| +68% | +$6.29M | ﹤0.01% | 2052 |
|
|
2023
Q1 | $7.27M | Buy |
73,730
+10,195
| +16% | +$1.38M | ﹤0.01% | 2908 |
|
|
2022
Q4 | $8.98M | Sell |
63,535
-2,870
| -4% | -$400K | ﹤0.01% | 2412 |
|
|
2022
Q3 | $9.31M | Sell |
66,405
-6,285
| -9% | -$1.15M | ﹤0.01% | 2251 |
|
|
2022
Q2 | $9.8M | Sell |
72,690
-2,515
| -3% | -$428K | ﹤0.01% | 2223 |
|
|
2022
Q1 | $23.6M | Buy |
75,205
+23,090
| +44% | +$8.7M | ﹤0.01% | 1572 |
|
|
2021
Q4 | $37.5M | Sell |
52,115
-4,465
| -8% | -$4.27M | 0.01% | 1308 |
|
|
2021
Q3 | $62.6M | Buy |
56,580
+2,865
| +5% | +$3.52M | 0.01% | 1017 |
|
|
2021
Q2 | $79.1M | Buy |
53,715
+25,075
| +88% | +$34.8M | 0.01% | 905 |
|
|
2021
Q1 | $45.2M | Buy |
28,640
+4,355
| +18% | +$10.2M | 0.01% | 1180 |
|
|
2020
Q4 | $48.8M | Sell |
24,285
-9,445
| -28% | -$15.1M | 0.01% | 1025 |
|
|
2020
Q3 | $36.1M | Buy |
33,730
+6,760
| +25% | +$7.75M | 0.01% | 1049 |
|
|
2020
Q2 | $32.1M | Buy |
26,970
+10,670
| +65% | +$9.25M | 0.01% | 1078 |
|
|
2020
Q1 | $7.35M | Sell |
16,300
-5,175
| -24% | -$4.71M | ﹤0.01% | 2101 |
|
|
2019
Q4 | $24.7M | Sell |
21,475
-215
| -1% | -$193K | 0.01% | 1244 |
|
|
2019
Q3 | $13.4M | Buy |
21,690
+480
| +2% | +$399K | ﹤0.01% | 1681 |
|
|
2019
Q2 | $21.3M | Buy |
21,210
+11,070
| +109% | +$10.7M | 0.01% | 1231 |
|
|
2019
Q1 | $12.1M | Sell |
10,140
-1,115
| -10% | -$1.16M | 0.01% | 1561 |
|
|
2018
Q4 | $7.4M | Sell |
11,255
-2,340
| -17% | -$2.45M | ﹤0.01% | 1880 |
|
|
2018
Q3 | $25.3M | Sell |
13,595
-6,780
| -33% | -$13.3M | 0.01% | 1149 |
|
|
2018
Q2 | $38.7M | Buy |
20,375
+7,595
| +59% | +$13.4M | 0.01% | 820 |
|
|
2018
Q1 | $20.3M | Sell |
12,780
-5,775
| -31% | -$10.8M | 0.01% | 1200 |
|
|
2017
Q4 | $28.9M | Buy |
18,555
+3,820
| +26% | +$5.85M | 0.01% | 1004 |
|
|
2017
Q3 | $25.2M | Buy |
14,735
+6,010
| +69% | +$8.34M | 0.01% | 1059 |
|
|
2017
Q2 | $11M | Sell |
8,725
-85
| -1% | -$85.8K | ﹤0.01% | 1622 |
|
|
2017
Q1 | $8.41M | Sell |
8,810
-9,260
| -51% | -$8.25M | ﹤0.01% | 1786 |
|
|
2016
Q4 | $11.3M | Sell |
18,070
-11,145
| -38% | -$8.37M | 0.01% | 1446 |
|
|
2016
Q3 | $28.5M | Buy |
29,215
+15,565
| +114% | +$12.8M | 0.01% | 793 |
|
|
2016
Q2 | $7.7M | Buy |
13,650
+11,600
| +566% | +$7.27M | ﹤0.01% | 1695 |
|
|
2016
Q1 | $1.12M | Buy |
2,050
+1,894
| +1,214% | +$1.2M | ﹤0.01% | 4850 |
|
|
2015
Q4 | $265K | Buy |
+156
| New | +$253K | ﹤0.01% | 7924 |
|
Other funds holding LABU
JF
TRCT
XT
HF
MIG
TSS
AF
Susquehanna International Group's LABU Position: Q1 2026 in Review
Susquehanna International Group increased its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 24% in Q1 2026, buying an estimated $2.12M and bringing the position to 67,050 shares worth $11.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2955.
Susquehanna International Group first reported a position in LABU in Q2 2015 and has held it in 31 quarters since. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2026.
- Susquehanna International Group held 67,050 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $11.1M as of Q1 2026.
- Susquehanna International Group bought 12,910 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2026, an estimated $2.12M.
- Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2955 holding.
- Susquehanna International Group first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2015 and has held it in 31 quarters since.
- 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.